SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-050808
Filing Date
2023-09-29
Accepted
2023-09-29 16:30:12
Documents
12
Period of Report
2023-09-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20230927.htm   iXBRL 8-K 49122
  Complete submission text file 0000950170-23-050808.txt   171293

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20230927_pre.xml EX-101.PRE 11116
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20230927.xsd EX-101.SCH 2483
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20230927_lab.xml EX-101.LAB 17588
6 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20230927_htm.xml XML 4546
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 231296120
SIC: 2834 Pharmaceutical Preparations